MAP1LC3A and hypopharynx cancer: High expression of LC3 in oral squamous cell cancer, esophageal cancer, and melanoma indicated a poor prognosis (Tang et al. 2013), while low expression of LC3 was associated with poor prognosis in hypopharyngeal cancer and renal clear cell cancer (Wang et al. 2013).